Vascularized composite allotransplantation: a member of the transplant family?

Stefan Schneeberger1, Emmanuel Morelon, Luis Landin

  • 1Center for Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria. stefan.schneeberger@i-med.ac.at

Transplantation
|May 18, 2012
PubMed

Insights

Vascularized composite allograft (VCA) definitions and allocation require specific considerations beyond solid organ transplants. This article addresses key aspects for developing a VCA allocation scheme, including donor factors and surgical procedures.

Area of Science:

  • Regenerative Medicine
  • Transplantation Immunology
  • Surgical Innovation

Background:

  • Vascularized composite allografts (VCAs) represent a complex frontier in transplantation.
  • Current transplantation frameworks do not fully encompass the unique challenges of VCA donation and allocation.
  • Standardization in VCA terminology and procedures is lacking.

Purpose of the Study:

  • To highlight the need for refined definitions and nomenclature for VCAs.
  • To identify critical factors for developing a comprehensive VCA allocation system.
  • To outline essential considerations for VCA donor operations and organ retrieval.

Main Methods:

  • Literature review and analysis of current transplantation protocols.
  • Comparative analysis of solid organ transplantation versus VCA requirements.
  • Discussion of ethical and logistical considerations in VCA allocation.

Main Results:

  • VCA allocation necessitates unique criteria, including donor identification, race, and bone constitution.
  • Specific algorithms are required for the surgical sequence during VCA donor retrieval.
  • Existing allocation schemes need adaptation to incorporate VCA-specific elements.

Conclusions:

  • Further interaction with regulatory bodies is crucial for VCA definition and nomenclature.
  • A tailored VCA allocation scheme is essential for successful transplantation.
  • Addressing donor-related factors and surgical protocols will advance VCA transplantation.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...